v3.25.2
Members' Deficit (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
May 31, 2022
Apr. 30, 2021
Jun. 11, 2018
May 20, 2018
Class A Member Units                
Members' Deficit                
Units issued         8,400,000     10,000,000
Value of units issued         $ 4.2     $ 0.1
Units purchased             16,666,666  
Exercise price             $ 0.01  
Value of units exercised           $ 0.2    
Price per unit         $ 0.5      
Remaining percentage of allocation of annual revenue and expenses on a pro rata basis 49.00% 49.00%            
Remaining percentage of allocation of voting interest on pro rata basis 49.00% 49.00%            
Remaining percentage of allocation of liquidation value on pro rata basis 49.00% 49.00%            
Class A Member Units | Valetudo Loan                
Members' Deficit                
Units repurchased       1,400,000        
Repurchase value       $ 0.7        
Repurchase price per unit       $ 0.5        
Class A Member Units | Metavagen | Metavagen License Agreement                
Members' Deficit                
Units exchanged       40,000,000        
Membership units terminated     40,000,000          
Class A Member Units | Curis Biotech Holdings LLC | CD47 License agreement with InnoBation                
Members' Deficit                
Units exchanged     78,555,554          
Class B Member Units                
Members' Deficit                
Percentage of allocation of annual revenue and expenses 51.00% 51.00%            
Percentage of voting interest 51.00% 51.00%            
Percentage of allocation of liquidation value 51.00% 51.00%